•  
  •  
 

Authors

Abstract

This article critiques critiques of clinical outcome studies carried out in Third World countries of Asia and Africa for new methods of AZT treatment that might affect the transmission of HIV from pregnant women to their infants. Some of these studies have been supported by the United States' Centers for Disease Control (CDC) and National Institutes of Health and opposed by several articles in The New England Journal of Medicine.